Spok (SPOK) to Release Quarterly Earnings on Wednesday

Spok (NASDAQ:SPOK) is set to release its earnings data after the market closes on Wednesday, May 1st. Spok has set its FY 2024 guidance at EPS.

Spok (NASDAQ:SPOK) last issued its quarterly earnings results on Wednesday, February 21st. The Wireless communications provider reported $0.17 earnings per share (EPS) for the quarter. Spok had a net margin of 11.27% and a return on equity of 9.43%. The company had revenue of $33.95 million during the quarter.

Spok Stock Down 0.7 %

Spok stock traded down $0.11 during trading on Thursday, reaching $15.44. The stock had a trading volume of 18,640 shares, compared to its average volume of 145,874. Spok has a 52-week low of $10.46 and a 52-week high of $18.14. The business has a 50 day moving average price of $16.31 and a 200 day moving average price of $15.90. The stock has a market cap of $310.96 million, a PE ratio of 20.08 and a beta of 0.26.

Spok Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 29th. Stockholders of record on Friday, March 15th were given a dividend of $0.313 per share. This represents a $1.25 annualized dividend and a dividend yield of 8.11%. The ex-dividend date was Thursday, March 14th. This is an increase from Spok’s previous quarterly dividend of $0.31. Spok’s payout ratio is currently 162.34%.

Insider Transactions at Spok

In other news, Director Todd J. Stein sold 25,927 shares of Spok stock in a transaction on Monday, March 4th. The shares were sold at an average price of $17.92, for a total value of $464,611.84. Following the transaction, the director now directly owns 696,637 shares of the company’s stock, valued at approximately $12,483,735.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 11.88% of the company’s stock.

Spok Company Profile

Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.